Multidrug-resistant organisms in patients from Ukraine in the Netherlands,March to August 2022 |
| |
Authors: | Romy D Zwittink Cornelia CH Wielders Daan W Notermans Nelianne J Verkaik Annelot F Schoffelen Sandra Witteveen Varisha A Ganesh Angela de Haan Jeroen Bos Jacinta Bakker Caroline Schneeberger-van der Linden Ed J Kuijper Sabine C de Greeff Antoni PA Hendrickx on behalf of the Dutch CPE MRSA Surveillance Study Groups |
| |
Affiliation: | 1.Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands;2.SWAB Working Group Surveillance of Antibiotic Resistance, Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands;3.The members of the network are acknowledged at the end of the article |
| |
Abstract: | Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine. |
| |
Keywords: | antimicrobial resistance patients from Ukraine CPE CPPA MRSA CRAB |
|
|